In this PharmTech interview experts discuss the implications of FDA’s new draft guidance on complying with 21 CFR 211.110.

In this PharmTech interview the topic of advances in small-molecule manufacturing is covered with several other experts commentaries.

Join our expert panel of scientists and FDA consultants as they explore the potential regulatory changes with the new administration.

This presentation provides an overview of the FDA's device pre-submission process and will examine the advantages of the Q-Sub program.

In this Ask the Expert video, experts discuss the new chapter, Chapter Bacterial Endotoxins Test Using Recombinant Reagents.

Click to learn from RCA's pharmaceutical consulting team about what is included in an effective Contamination Containment Strategy.

Click to learn how RCA Pharmaceutical consultants make an accurate assessment of an organization’s environmental monitoring program.

Click to learn more about FDA's recently announced partnerships with collaborative communities to enhance regulatory speed-to-market.